Abstract
Using biochemical assays, we compared enzyme activities with the immunoreactivity of antibodies against rat seminal transglutaminase (TGase), human erythrocyte TGase and guinea pig liver TGase in human normal prostate, primary prostatic carcinomas and prostatic carcinoma cell lines. Glandular cells of the epithelium were only exceptionally positive with the antibody against (rat) secretory TGase. Using the antibodies against tissue-type TGase, most immunoreactive cells were found in the basal cell layer of prostatic epithelium as well as in stroma (fibroblasts, endothelial cells), whereas immunoreactive glandular cells were sparse. In the case of benign prostatic hyperplasia, few, irregularly distributed secretory cells along with a small number of stromal cells were also immunoreactive with the tissue-type TGase antibody. In dedifferentiated carcinomas, immunoreactive cells were nearly completely absent. Of the prostate cancer cell lines, the LNCaP line showed neither TGase enzyme activity nor immunoreactivity, whereas the PC-3 cell line displayed significant enzyme activity and immunoreactivity. No hormone-dependent changes in either enzyme activity or immunoreactivity were recorded after in vitro treatment of the respective cell lines with estrogens, androgens and antiandrogens. As there is no correlation between androgen deprivation and TGase expression in nonmalignant and malignant human prostatic epithelial cells, TGase activity more likely indicates cellular lesions and consecutive repair mechanisms.
Similar content being viewed by others
References
Achyuthan KE, Greenberg CS (1987) Identification of a GTP-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. J Biol Chem 262:1901
Aeschlimann D, Paulsson M (1991) Cross-linking of lamininnidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization. J Biol Chem 266:15308
Aumüller G, Seitz J, Bischof W (1983) Immunohistochemical study on the initiation of acid phosphatase secretion in the human prostate. J Androl 4:183
Bacher M, Rausch U, Goebel HW, Polzar B, Mannherz HG, Aumüller G (1993) Hormonal regulation of stromal cells from rat ventral prostate during androgen deprivation and estrogen treatment. Exp Clin Endocrinol 101:79
Barnes RN, Bungay PJ, Elliot BM, Walton PL, Griffin M (1985) Alterations in the distribution and activity of transglutaminase during tumor growth and metastasis. Carcinogenesis 6:456
Barsigian C, Stern AM, Martinez J (1991) Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. J Biol Chem 266:22501
Bergamini CM, Signorini M, Poltronieri L (1987) Inhibition of erythrocyte transglutaminase by GTP. Biochim Biophys Acta 916:149
Birckbichler PJ, Orr GR, Conway E, Patterson MK Jr (1977) Transglutaminase activity in normal and transformed cells. Cancer Res 37:1340
Birckbichler PJ, Orr GR, Patterson MK Jr, Conway E, Carter HA (1981) Increase in proliferative markers after inhibition of transglutaminase. Proc Natl Acad Sci USA 78:5005
Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248
Brenner SC, Wold F (1978) Human erythrocyte transglutaminase. Purification and properties. Biochim Biophys Acta 522:74
Bungay PJ, Potter JM, Griffin M (1984) A role for polyamines in stimulus/secretion coupling in the pancreatic β-cell. Biosci Rep 4:869
Byrd JC, Lichti U (1987) Two types of transglutaminase in the PC 12 pheochromocytoma cell line. J Biol Chem 262:11699
Candido EPM, Reeves R, Davie JR (1978) Sodium butyrate inhibits histone deacetylation in cultured cells. Cell 14:105
Eicheler W, Tuohimaa P, Vilja P, Adermann K, Forssmann WG, Aumüller G (1994) Immunocytochemical localization of human 5α-reductase 2 with polyclonal antibodies in androgen target and non-target human tissues. J Histochem Cytochem 42:667
El Alaoui S, Legastelois S, Roch AM, Qash G (1991) Transglutaminase activity and N ε (γ-glutamyl) lysine isopeptide levels during cell growth: an enzymic and immunologic study. Int J Cancer 48:221
Fair WR (1992) The natural history of locally confined prostate cancer: a review. Prostate [Suppl] 4:79
Fésüs L, Davies PJA, Piacentini M (1991) Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol 56:170
Folk JE, Chung SI (1985) Molecular and catalytic properties of transglutaminases. Adv Enzymol 38:109
Graham RC, Karnovsky MJ (1966) The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney. J Histochem Cytochem 14:291
Greenberg CS, Birckbichler PJ, Rice RH (1991) Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5:3071
Grundmann U, Amann E, Zettelmeissl G, Kupper HA (1986) Characterization of cDNA coding for human factor XIIIa. Proc Natl Acad Sci USA 83:8024
Hand D, Elliot BM, Griffin M (1987) Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis. Biochim Biophys Acta 1053:13
Ho KC, Quarmby VE, French FS, Wilson EM (1992) Molecular cloning of rat prostate transglutaminase complementary DNA. J Biol Chem 267:12660
Ichinose A, Bottenus RE, Davie EW (1990) Structure of transglutaminases. J Biol Chem 265:13411
Ikura K, Nasu T, Yokota H, Tsuchiya Y, Sasaki R, Chiba H (1988) Amino acid sequence of guinea pig liver transglutaminase from its cDNA sequences. Biochemistry 27:2898
Piacentini M, Fésüs L, Farace MG, Ghibelli L, Piredda L, Mellino G (1991) The expression of “tissue” transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur J Cell Biol 54:246
Polakowska R, Herting E, Goldsmith LA (1991) Isolation of cDNA for human epidermal type I transglutaminase. J Invest Dermatol 96:285
Romijn JC, Verkoelen CF, Schroeder FH (1989) Analysis of transglutaminase activities in prostate cancer cells: relationship with metastatic potential. Urol Res 17:331
Seitz J, Keppler C, Hüntemann S, Rausch U, Aumüller G (1991) Purification and molecular characterization of a secretory transglutaminase from coagulating gland of the rat. Biochim Biophys Acta 1078:139
Slife CW, Dorsett MD, Tillotson ML (1985) Subcellular location and identification of a large molecular weight substrate for the liver plasma membrane transglutaminase. J Biol Chem 261:3451
Steinhoff M, Seitz J, Eicheler W, Hoffbauer G, Aumüller G (1992) Hormone-dependence of apocrine secretion in rat coagulating gland. Eur J Cell Biol 57 [Suppl]:36
Sternberger LA, Hardy PH Jr, Cuculis JJ, Meyer HG (1970) The unlabeled antibody enzyme method of immunohistochemistry. J Histochem Cytochem 18:315
Thomázy V, Fésüs L (1989) Differential expression of tissue transglutaminase in human cells. An immunohistochemical study. Cell Tissue Res 255:215
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350
Turnock K, Bulmer JN, Gray C (1990) Phenotypic characterization of macrophage subpopulations and localization of factor XIII in the stromal cells of carcinomas. Histochem J 22:661
Upchurch HF, Conway E, Patterson MK Jr, Maxwell MD (1991) Localization of cellular transglutaminase on the extracellular matrix after wounding: characteristics of the matrix bound enzyme. J Cell Physiol 149:375
Williams-Ashman HG (1984) Transglutaminases and the clotting of mammalian seminal fluids. Mol Cell Biochem 58:51
Wunsch A, Rausch U, Seitz J, Goebel HW, Friedrichs B, Aumüller G (1992) Tissue-type transglutaminase expression in the Dunning tumor. Urol Res 21:9
Zirvi KA, Keogh JP, Slomiany A, Slomiany BL (1991) Transglutaminase activity in human colorectal carcinomas of differing metastatic potential. Cancer Lett 60:85
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Friedrichs, B., Riedmiller, H., Goebel, HW. et al. Immunological characterization and activity of transglutaminases in human normal and malignant prostate and in prostate cancer cell lines. Urol. Res. 23, 301–310 (1995). https://doi.org/10.1007/BF00300018
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00300018